Mostrando 10 resultados de: 15
Filtros aplicados
Publisher
Journal of Clinical Rheumatology(6)
Clinical Rheumatology(4)
Annals of the Rheumatic Diseases(1)
Biologics: Targets and Therapy(1)
GaBI Journal(1)
Área temáticas
Farmacología y terapéutica(10)
Enfermedades(9)
Historia de Sudamérica(1)
Problemas sociales y servicios a grupos(1)
Relaciones internacionales(1)
Área de conocimiento
Medicina interna(3)
Salud pública(2)
Cuidado de la salud(1)
Educación superior(1)
Farmacología(1)
Origen
scopus(15)
Clinical pbkp_redictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort
ArticleAbstract: Objectives: To identify baseline pbkp_redictors of remission and low disease activity (LDA) in earlyPalabras claves:Early RA outcomes, Early RA remission, Early RA response pbkp_redictors, Latin America early RAAutores:Achurra-Castillo A.F., Alarcón G.S., Andrade-Ortega L., Appenzeller S., Ballesteros F., Barile-Fabris L.A., Bianchi W.A., Caballero-Uribe C.V., Cardiel M.H., Castelar-Pinheiro G.d.R., Claudio M. Galarza-Maldonado, Da Silveira I.G., de Freitas Zerbini C.A., Esquivel-Valerio J.A., Esteva-Spinetti M.H., Gamboa-Cárdenas R.V., García de la Torre I., Guibert-Toledano M., Loreto M., Monge P., Montufar R.A., Palezuelos F.I., Pisoni C.N., Pons-Estel B.A., Radominski S.C., Rios C., Rojas-Villarraga A., Sacnun M.P., Saurit V., Soriano E.R., Teijeiro R., Ugarte-Gil M.F., Vazquez-Mellado J.Fuentes:scopusA Consensus Position Paper from REAL-PANLAR Group about the Methodological Approach for the Accbkp_reditation Process of Centers of Excellence in Rheumatoid Arthritis in Latin America
ArticleAbstract: Background By 2015, the World Health Organization reported that 1% of the world population sufferedPalabras claves:accbkp_reditation, Latin America, quality of health care, Rheumatoid Arthritis, standard of careAutores:Caballero-Uribe C.V., Cardiel M.H., Castro-Moreno C., Claudio M. Galarza-Maldonado, Diana Carolina Buitrago-García, Massardo L., Pineda-Villaseñor C., Santos-Moreno P., Soriano E.R., Villarreal L.Fuentes:scopusCorrection to: PANLAR consensus statement on biosimilars (Clinical Rheumatology, (2019), 38, 5, (1485-1496), 10.1007/s10067-019-04496-3)
OtherAbstract: The two co-authors of the mentioned above article were incorrect. The correct are authors should havPalabras claves:Autores:Avila-Pedretti G., Azevedo V.F., Babini A.M., Beltrán P.A., Benavides J.A., Caballero-Uribe C.V., Cachafeiro-Vilar A., Cifuentes-Alvarado M., Claudio M. Galarza-Maldonado, Cohen S.B., Díaz P.E., Díaz-Coto J.F., Encalada C., Firedman D.X.X., Garro B., Guibert-Toledano M., Kay J., Kowalski S.C., Lopez M.E.L., Mysler E., Ortega A.P., Pineda-Villaseñor C., Rodriguez V.J.K., Russell A.S., Santos-Moreno P., Sariego I.A.G., Soriano E.R., Terán I.S., Vargas A., Vásquez G., Xavier R.M.Fuentes:scopusCurrent therapies in rheumatoid arthritis: A Latin American perspective
OtherAbstract: Rheumatoid arthritis (RA) is a systemic inflammatory disease affecting the synovium of joints, tendoPalabras claves:Biologic therapy, Latin America, practice guidelines, Rheumatoid Arthritis, Socioeconomic factorsAutores:Burgos-Vargas R., Cardiel M.H., Catoggio L.J., Claudio M. Galarza-Maldonado, Ostojich K.Fuentes:scopusCurrent trends for biosimilars in the Latin American market
ArticleAbstract: The number of approved biological medicines in the global pharmaceutical market has increased in recPalabras claves:Biologicals, biopharmaceuticals, Biosimilars, Latin AmericaAutores:Claudio M. Galarza-Maldonado, Dámaris P. Intriago-Baldeón, Diana C. Checa-Jaramilloz, Diana Castillo, Esteban Ortiz-Prado, Felipe Andrade, Jorge Eduardo Vásconez, Nathalia Rodríguez-Burneo, Ponce-Zea J.Fuentes:scopusFirst Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatology (PANLAR)
ArticleAbstract: Systemic lupus erythematosus (SLE), a complex and heterogeneous autoimmune disease, represents a sigPalabras claves:lupus nephritis, systemic lupus erythematosus, TreatmentAutores:Acevedo-Vásquez E.M., Acosta Colman M.I., Alarcón G.S., Alba Moreyra P.B., Alvarellos A.J., Amezcua-Guerra L.M., Amigo M.C., Appenzeller S., Aquino A.M., Arturi V., Babini A.M., Barile-Fabris L.A., Berbotto G.A., Betancur G.V., Bonfá E.S.D.D.O., Borba E.F., Brenol J.C.T., Burgos P.I., Cairoli E., Cardiel M.H., Cardoso Linhares F.A., Catoggio L.J., Cavalcanti A., Cavalcanti F.S., Chacón-DÍaz R., Cieza J., Claudio M. Galarza-Maldonado, Collado M.V., Conti S.M., Costallat L.T.L., Criniti J.M., Da Silva N.A., Danza A., Dos Reis Neto E.T., Drenkard C., Duarte M., Eraso Garnica R.M., Espada G., Fragoso-Loyo H.E., Fuentes-Silva Y.J., Gamboa-Cárdenas R.V., García de la Torre I., García M.A., García Valladares I., Gerling C., Gervasoni V.L., Gobbi C.A., Gómez-Martín D., Gómez-Puerta J.A., González Naranjo L.A., González-Bello Y.C., Gordon S., Guibert-Toledano M., Haye Salinas M.J., Herrera Uribe S., Iglesias Gamarra A.J., Izcovich A., Levy R.A., Llanos C., Massardo L., Molina J.F., Montandon De Oliveira E Silva A.C., Monticielo O.A., Montúfar Guardado R.A., Mora-Trujillo C.S., Muñoz-Louis R., Neira O., Orozco M.C., Pera M.A., Pineda-Villaseñor C., Pons-Estel B.A., Pons-Estel G.J., Popoff F., Portela Hernández M., Quintana R.M., Retamozo S., Reyes G.L., Robaina Sevrini R., Rosario V., Sarano J., Sato E.I., Sattler M.E., Saurit V., Savio V., Scherbarth H.R., Scolnik M., Seguro L.P.C., Silva C.A., Silveira L.H., Soriano E.R., Ugarte-Gil M.F., Ugolini-Lopes M.R., Vargas Peña A., Vásquez G., Xavier R.M.Fuentes:scopusPANLAR consensus statement on biosimilars
ArticleAbstract: Introduction: Biologics have improved the treatment of rheumatic diseases, resulting in better outcoPalabras claves:Biosimilars, consensus, PANLAR, Rheumatic diseasesAutores:Avila-Pedretti G., Azevedo V.F., Babini A.M., Benavides J.A., Caballero-Uribe C.V., Cachafeiro-Vilar A., Cifuentes-Alvarado M., Claudio M. Galarza-Maldonado, Cohen S.B., Díaz P.E., Encalada C., Firedman D.X.X., Garro B., Guibert-Toledano M., Kay J., Kowalski S.C., Lopez M.E.L., Mysler E., Ortega A.P., Pineda-Villaseñor C., Roa P.A.B., Rodriguez V.J.K., Russell A.S., Santos-Moreno P., Sariego I.A.G., Soriano E.R., Soto L.D., Terán I.S., Vargas A., Vásquez G., Xavier R.M.Fuentes:scopusPan-American league of associations for rheumatology (PANLAR) recommendations and guidelines for musculoskeletal ultrasound training in the americas for rheumatologists
ArticleAbstract: Objective: To develop guidelines for Musculoskeletal Ultrasound (MSKUS) training for rheumatologistsPalabras claves:American continent, consensus, Courses, Musculoskeletal ultrasound, recommendations, Teaching, TRAININGAutores:Aliste M., Alva M., Aragón-Laínez R.A., Bouffard J.A., Caballero-Uribe C.V., Chávez-López M., Chávez-Pérez N.N., Claudio M. Galarza-Maldonado, Collado P., Da Silveira I.G., Díaz-Coto J.F., Duarte M., Filippucci E., Flores V., García-Kutzbach A., González A.B., González-Sevillano E., Gutiérrez M., Hernández J.A., Hernández-Díaz C., Javier Godoy F., Lamuño-Encorrada M., Marcos J.C., Marín-Arriaga N., Mendonça J.A., Michaud J., Möller I., Moya C., Muñoz-Louis R., Naredo E., Neubarth F., Pineda-Villaseñor C., Quintero M., Reginato A.M., Reyes B., Rodríguez-Henríquez P.J., Ruta S., Solano C., Ventura-Ríos L.Fuentes:scopusManagement of patients with rheumatoid arthritis in latin america: A consensus position paper from pan-american league of associations of rheumatology and grupo latino americano de estudio de artritis reumatoide
ArticleAbstract: OBJECTIVE:: A consensus meeting of representatives of 18 Latin-American and Caribbean countries gathPalabras claves:diagnosis, Latin America, Rheumatoid Arthritis, TreatmentAutores:Acevedo-Vázquez E., Caballero-Uribe C.V., Cardiel M.H., Claudio M. Galarza-Maldonado, Espinosa-Morales R., Laurindo I.M., Levy R.A., Massardo L., Millán A., Nava A., Pineda-Villaseñor C., Pons-Estel B.A., Soriano E.R., Suárez-Almazor M.E.Fuentes:scopusIs Tofacitinib Effectiveness in Patients with Rheumatoid Arthritis Better After Conventional Than After Biological Therapy? – A Cohort Study in a Colombian Population
ArticleAbstract: Purpose: Tofacitinib is recommended for treatment of rheumatoid arthritis (RA) in patients with modePalabras claves:biologics, Rheumatoid Arthritis, tofacitinib, TreatmentAutores:Claudio M. Galarza-Maldonado, Ibata L., Martinez S., Rivero M., Rodríguez-Florido F., Rojas-Villarraga A., Santos-Moreno P., Villarreal L.Fuentes:scopus